[1] Weiss K,Lotz-Havla A,Dokoupil K,et al.Management of three preterm infants with phenylketonuria[J].Nutrition,2020,71:110619. [2] de Almeida B,Laufer J,Mezzomo T,et al.Nutritional and metabolic parameters of children and adolescents with phenylketonuria[J].Clinical Nutrition ESPEN,2020,37:44-49. [3] 张志强,龙艳明,钟继生,等.串联质谱技术在广东省惠州地区新生儿遗传性代谢病筛查中的应用研究[J].检验医学与临床,2020,17(3):411-413. [4] 中华医学会医学遗传学分会遗传病临床实践指南撰写组. 苯丙酮尿症的临床实践指南[J].中华医学遗传学杂志,2020,37(3):226-234. [5] Vardy E,MacDonald A,Ford S,et al.Phenylketonuria,co-morbidity,and ageing:A review[J].JIMD,2020,43(2):167-178. [6] Hillert A,Anikster Y,Belanger-Quintana A,et al.The genetic landscape and epidemiology of phenylketonuria[J].Am J Hum Genet,2020,107(2):234-250. [7] Abdelaziz RB,Chehida AB,Kachouri H,et al.Quality of life and associated factors in parents of children with late diagnosed phenylketonuria. A cross sectional study in a developing country (Tunisia) [J].JPEM,2020,33(7):901-113. [8] Liu N,Huang Q,Li Q,et al.Spectrum of PAH gene variants among a population of Han Chinese patients with phenylketonuria from northern China[J].BMC Medical Genetics,2017,18(1):108. [9] Wang L,Ye F,Zou H,et al.The first study of successful pregnancies in Chinese patients with Phenylketonuria[J].BMC Pregnancy and Childbirth,2020,20(1):253. [10] 韩宗兰,王兰英,王海楠,等.影响苯丙酮尿症患儿生活质量的相关因素及干预措施[J].中国医药导报,2019,16(6):90-93. [11] 于青,屈萍,张娜,等.232213例新生儿苯丙酮尿症筛查结果分析[J].临床医学研究与实践,2019,4(7):106-107. [12] 张延娜,梁思颖,陆薇冰,等.青岛地区29万例新生儿苯丙酮尿症筛查结果及患者PAH基因突变研究分析[J].中国优生与遗传杂志,2019,27(6):733-735,745. [13] 李宇宁. 苯丙酮尿症的诊疗进展[J].甘肃科技,2001,17(3):30-31. |